| | |

Two New Diagnostic Tissue Biomarkers Discovered for Mesothelioma

ByHolly Zink

Two New Diagnostic Tissue Biomarkers Discovered for MesotheliomaScientists have now identified two new diagnostic tissue biomarkers for malignant pleural mesothelioma.

Doctors identify mesothelioma using diagnostic tissue biomarkers. This is called immunohistochemistry.

The use of immunohistochemistry improves the accuracy of mesothelioma diagnosis in clinical practice. Yet, new methods for discovering diagnostic markers are still needed.

Following a Reverse Approach in a Rare Case

Mesothelioma is usually diagnosed after a person experiencing symptoms goes to a doctor. One thing a doctor may do is perform a tissue biopsy. The doctor will remove a part of the tissue (suspected mesothelioma) for examination.

Most tissue biopsies are done with a needle and then examined in a laboratory. The lab will look for specific biomarkers to find out if the tissue contains mesothelioma.

Japanese scientists have now used a reverse clinical approach on an archival tissue sample. They identified two new diagnostic tissue biomarkers for malignant pleural mesothelioma.

Microbiologists used gene expression profiling to analyze 54 genes. This analysis identified two new diagnostic tissue biomarkers, PHGDH and TRIM29.

Pathologists performed further immunohistochemical analysis on 48 mesothelioma and 20 pulmonary adenocarcinoma patients. Pulmonary adenocarcinoma is the most common lung cancer in the United States.

Diagnosing Mesothelioma Faster

Many mesothelioma patients have a misdiagnosis or a delay in diagnosis.

A tissue biopsy is an important step in being diagnosed correctly. A biopsy can help doctors determine the cell type of the disease. This is important information that can be used to create an effective treatment plan.

These two new diagnostic tissue biomarkers can be used to diagnose mesothelioma quickly. Doctors can now tell the difference between mesothelioma and other cancers.

Scientists used mesothelioma patient surgical tissue samples between 2000 and 2003. The tissue microarray was prepared using a complex protocol.

This successful reverse translational approach is encouraging. Scientists can use similar protocols for the development of other novel diagnostic markers.

Possible Indicators of Poor Prognosis

Others have reported that PHGDH and TRIM29 biomarkers are clear in lung cancer. They are indicators of poor prognosis in lung cancer.

This study did not investigate indicators of prognosis in mesothelioma. The prognostic application of these two new diagnostic tissue biomarkers is unknown. Future research will need to be conducted in mesothelioma samples.

Reporting Two New Markers for the First Time

Two new diagnostic tissue biomarkers have been identified for malignant pleural mesothelioma. These biomarkers are PHGDH and TRIM29.

Scientists used a reverse translational approach. The discovery was based on a very rare single case.

Dr. Tomoaki Naka of Hokkaido University noted that this discovery “encourages the further use of such samples for the development of novel diagnostic markers.”

The diagnostic utility of these markers is particularly useful. It allows for the distinction between mesothelioma and pulmonary adenocarcinoma tumors.

Sources

Naka, T., Hatanaka, Y., Tabata, Y., Takasawa, A., Akiyama, H., Hida, Y., … & Matsuno, Y. (2022). Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor. Diagnostics, 12(2), 316. https://doi.org/10.3390/diagnostics12020316

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    ByAlex Strauss

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Blood Test May Be Possible

    ByAlex Strauss

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    ByAlex Strauss

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Inflammation Both “Friend and Foe” in Mesothelioma

    ByAlex Strauss

    An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…

  • | |

    FDG PET-CT Results Could Lead to Improved Mesothelioma Treatment

    ByAlex Strauss

    In a recent study, researchers say a better understanding of certain diagnostic criteria could result in more targeted treatments for malignant mesothelioma. In a recent published report, doctors from the medical school at Dicle University in Diyarbakir, Turkey measured the relationship between PET-CT scan results and survival in 177 patients with malignant pleural mesothelioma. The patients were diagnosed between April 2007 and April 2011. They had a mean age of 55.4 and most (56%) were male. Patients in the study all had FDG PET-CT scans before beginning their mesothelioma treatment. FDG PET-CT scanning is a powerful imaging tool for mesothelioma and other cancers that combines a radioactive tracer with a combination of positron emission tomography and computed tomography scanning.  Because…